Dr Esmond Fong obtained his medical degree from the University of Hong Kong. He completed his residency in internal medicine, fellowship in general and interventional cardiology at Queen Elizabeth Hospital, Hong Kong. He subsequently obtained his fellowship in peripheral intervention at Massachusetts General Hospital, Harvard Medical School in Boston, US. He is currently an Associate Consultant at Queen Elizabeth hospital. His clinical interests include cardiogenic shock, CHIP/ complex coronary interventions, Interventions in peripheral vascular disease, pulmonary embolism and venous diseases. He is currently the physician-in-charge for peripheral intervention at Queen Elizabeth Hospital.
Dr. Esmond Yan Hang Fong is an Associate Consultant in Cardiology and Internal Medicine at Queen Elizabeth Hospital in Hong Kong. He is a highly trained specialist with a focus on vascular diagnostic and interventional procedures, having completed a clinical and research fellowship at Massachusetts General Hospital, Harvard Medical School. Dr. Fong is a Fellow of the Hong Kong College of Physicians (FHKCP), the Hong Kong Academy of Medicine (FHKAM), and the American College of Cardiology (FACC).
In addition to his clinical role, Dr. Fong serves as an Honorary Clinical Assistant Professor at both the Chinese University of Hong Kong and the University of Hong Kong. He is the Founding President of the Innovative Cardiovascular Initiative and an Associate Director for AICT-AsiaPCR. His expertise in peripheral intervention and heart failure service is complemented by a strong research background, including acting as a Site PI for the FINEARTS study and a reviewer for AsiaIntervention. He has performed over 4,000 diagnostic coronary angiographies and 2,800 percutaneous coronary interventions.